These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 11202944)
1. Role of spironolactone in heart failure should be emphasised. Mapstone J; Houston B; Gogarty M BMJ; 2000 Sep; 321(7262):706-7. PubMed ID: 11202944 [No Abstract] [Full Text] [Related]
2. [Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options]. Diercks GF; Overdiek JW; van Veldhuisen DJ Ned Tijdschr Geneeskd; 2001 Feb; 145(5):204-8. PubMed ID: 11219145 [TBL] [Abstract][Full Text] [Related]
3. Spironolactone for heart failure: a worthy addition to therapy. Rittenhouse SK Adv Nurse Pract; 2001 Jan; 9(1):34-6, 39. PubMed ID: 12416036 [No Abstract] [Full Text] [Related]
4. [Chronic heart insufficiency should be treated also with spironolactone]. Kjeldsen KP; Nørgaard A; Thygesen K Ugeskr Laeger; 1999 Sep; 161(37):5132. PubMed ID: 10523942 [No Abstract] [Full Text] [Related]
5. Spironolactone in left-sided heart failure: how does it fit in? Margo KL; Luttermoser G; Shaughnessy AF Am Fam Physician; 2001 Oct; 64(8):1393-8. PubMed ID: 11681781 [TBL] [Abstract][Full Text] [Related]
6. [New evidence for the usefulness of an old drug in the treatment of heart failure]. Oseguera Moguel J Rev Invest Clin; 2000; 52(1):14-6. PubMed ID: 10818804 [No Abstract] [Full Text] [Related]
7. New hope for heart failure. DeMaria A Health News; 1999 Sep; 5(11):1-2. PubMed ID: 10513252 [No Abstract] [Full Text] [Related]
8. What's old is new again. Spironolactone and heart failure. Lock M; Chun R Can Fam Physician; 1999 Nov; 45():2621-2. PubMed ID: 10587769 [No Abstract] [Full Text] [Related]
9. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure. Bauersachs J; Fraccarollo D Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071 [TBL] [Abstract][Full Text] [Related]
10. Effect of spironolactone on C-reactive protein levels in patients with heart disease. Godfrey V; Farquharson CA; Macdonald JE; Yee KM; Struthers AD Int J Cardiol; 2007 Apr; 117(2):282-4. PubMed ID: 16899309 [TBL] [Abstract][Full Text] [Related]
11. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Bansal S; Lindenfeld J; Schrier RW Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361 [TBL] [Abstract][Full Text] [Related]
12. Curriculum in cardiology: Integrated diagnosis and management of diastolic heart failure (Am Heart J 2007;153:189-200). Jolobe OM Am Heart J; 2007 Jul; 154(1):e5; author reply e7. PubMed ID: 17584543 [No Abstract] [Full Text] [Related]
13. Slow adoption of helpful heart failure drug. Many people who could benefit from spironolactone aren't getting it. Harv Heart Lett; 2010 Feb; 20(6):2. PubMed ID: 20376944 [No Abstract] [Full Text] [Related]
17. [The process of drug development. The "case" of spironolactone]. De Feo S; Opasich C; Volpi A; Tavazzi L Ital Heart J Suppl; 2002 Feb; 3(2):178-86. PubMed ID: 11926024 [TBL] [Abstract][Full Text] [Related]
18. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. Gao X; Peng L; Adhikari CM; Lin J; Zuo Z J Card Fail; 2007 Apr; 13(3):170-7. PubMed ID: 17448413 [TBL] [Abstract][Full Text] [Related]
19. [The significance of aldosterone in chronic heart failure: the RALES study]. Simko F; Bada V; Simková M; Simko J; Kovács L; Hulín I Vnitr Lek; 2002 Aug; 48(8):767-72. PubMed ID: 12425209 [TBL] [Abstract][Full Text] [Related]
20. Aldosterone antagonism and atrial fibrillation: time for clinical assessment? Nattel S Eur Heart J; 2005 Oct; 26(20):2079-80. PubMed ID: 16141259 [No Abstract] [Full Text] [Related] [Next] [New Search]